Stockreport

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates [Yahoo! Finance]

Athira Pharma, Inc.  (ATHA) 
PDF On-track to enable dosing ALS patients in 2025 BOTHELL, Wash., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutica [Read more]